KR101790286B9 - -3-디메틸아미노프로폭시]-3'-메톡시비벤질 또는 그의 염을 포함하는 경구용 약학 조성물 - Google Patents

-3-디메틸아미노프로폭시]-3'-메톡시비벤질 또는 그의 염을 포함하는 경구용 약학 조성물

Info

Publication number
KR101790286B9
KR101790286B9 KR1020160029881A KR20160029881A KR101790286B9 KR 101790286 B9 KR101790286 B9 KR 101790286B9 KR 1020160029881 A KR1020160029881 A KR 1020160029881A KR 20160029881 A KR20160029881 A KR 20160029881A KR 101790286 B9 KR101790286 B9 KR 101790286B9
Authority
KR
South Korea
Prior art keywords
methoxybibenzyl
carboxypropionyloxy
dimethylaminopropoxy
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
KR1020160029881A
Other languages
English (en)
Other versions
KR20170106126A (ko
KR101790286B1 (ko
Inventor
최연웅
하대철
권인호
김아영
송희용
정래훈
최보람
Original Assignee
한국유나이티드제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59789653&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101790286(B9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 한국유나이티드제약 주식회사 filed Critical 한국유나이티드제약 주식회사
Priority to KR1020160029881A priority Critical patent/KR101790286B1/ko
Priority to PCT/KR2017/002614 priority patent/WO2017155350A1/ko
Priority to CN201780028153.9A priority patent/CN109069435B/zh
Priority to JP2018547975A priority patent/JP7366542B2/ja
Publication of KR20170106126A publication Critical patent/KR20170106126A/ko
Application granted granted Critical
Publication of KR101790286B1 publication Critical patent/KR101790286B1/ko
Publication of KR101790286B9 publication Critical patent/KR101790286B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020160029881A 2016-03-11 2016-03-11 (±)-2-[2-(3-카르복시프로피오닐옥시)-3-디메틸아미노프로폭시]-3'-메톡시비벤질 또는 그의 염을 포함하는 경구용 약학 조성물 KR101790286B1 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
KR1020160029881A KR101790286B1 (ko) 2016-03-11 2016-03-11 (±)-2-[2-(3-카르복시프로피오닐옥시)-3-디메틸아미노프로폭시]-3'-메톡시비벤질 또는 그의 염을 포함하는 경구용 약학 조성물
PCT/KR2017/002614 WO2017155350A1 (ko) 2016-03-11 2017-03-10 (±)-2-[2-(3-카르복시프로피오닐옥시)-3-디메틸아미노프로폭시]-3'-메톡시비벤질 또는 그의 염을 포함하는 경구용 약학 조성물
CN201780028153.9A CN109069435B (zh) 2016-03-11 2017-03-10 包含沙格雷酯或其盐的口服药物组合物
JP2018547975A JP7366542B2 (ja) 2016-03-11 2017-03-10 （±）－２－［２－（３－カルボキシプロピオニルオキシ）－３－ジメチルアミノプロポキシ］－３’－メトキシビベンジルまたはその塩を含む経口用薬学組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160029881A KR101790286B1 (ko) 2016-03-11 2016-03-11 (±)-2-[2-(3-카르복시프로피오닐옥시)-3-디메틸아미노프로폭시]-3'-메톡시비벤질 또는 그의 염을 포함하는 경구용 약학 조성물

Publications (3)

Publication Number Publication Date
KR20170106126A KR20170106126A (ko) 2017-09-20
KR101790286B1 KR101790286B1 (ko) 2017-10-26
KR101790286B9 true KR101790286B9 (ko) 2022-01-28

Family

ID=59789653

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160029881A KR101790286B1 (ko) 2016-03-11 2016-03-11 (±)-2-[2-(3-카르복시프로피오닐옥시)-3-디메틸아미노프로폭시]-3'-메톡시비벤질 또는 그의 염을 포함하는 경구용 약학 조성물

Country Status (4)

Country Link
JP (1) JP7366542B2 (ko)
KR (1) KR101790286B1 (ko)
CN (1) CN109069435B (ko)
WO (1) WO2017155350A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102261748B1 (ko) 2019-02-13 2021-06-08 한국바이오켐제약 주식회사 사포그릴레이트염산염의 제조방법 및 이를 포함하는 약학제제
JP2023510140A (ja) * 2019-12-19 2023-03-13 セルトリオン， インク． シベンゾリンまたはその塩を含む薬学剤形

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101320802B1 (ko) * 2010-02-16 2013-10-23 주식회사 드림파마 방출 제어형 사포그릴레이트 염산염 함유 다층 정제
KR101265491B1 (ko) * 2010-08-30 2013-05-16 주식회사 유유제약 사포그릴레이트염산염을 함유하는 용출률이 조절된 경구용 다층정제 및 이의 제조방법
KR20120060983A (ko) * 2010-10-04 2012-06-12 근화제약주식회사 염산사포그릴레이트를 포함하는 서방화 제제 및 이의 제조방법
KR101534606B1 (ko) * 2011-11-08 2015-07-10 알보젠코리아 주식회사 사포그릴레이트의 안정화된 지속 방출 제제
CN102552165B (zh) * 2012-01-05 2014-07-16 金陵药业股份有限公司 一种盐酸沙格雷酯缓释微丸及其制备方法
CN103284970A (zh) * 2012-02-29 2013-09-11 锦华制药株式会社 盐酸沙格雷酯缓释制剂及制备方法
KR20130135493A (ko) * 2012-06-01 2013-12-11 씨제이제일제당 (주) 안정화된 사포그릴레이트 염산염을 포함하는 경구용 서방성 매트릭스 제제 및 그의 제조방법
MX362838B (es) 2012-07-12 2019-02-19 SpecGx LLC Composiciones farmacéuticas de liberación prolongada para disuadir el abuso de opioides que comprenden un plastómero, un elastómero y un plastificante delicuescente.

Also Published As

Publication number Publication date
WO2017155350A1 (ko) 2017-09-14
CN109069435B (zh) 2022-06-28
JP7366542B2 (ja) 2023-10-23
KR20170106126A (ko) 2017-09-20
KR101790286B1 (ko) 2017-10-26
JP2019507795A (ja) 2019-03-22
CN109069435A (zh) 2018-12-21

Similar Documents

Publication Publication Date Title
IL283134A (en) Formulations of alcohol-resistant drugs
IL257481B (en) Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereof
HK1244704A1 (zh) 一種含有jak激酶抑制劑或其可藥用鹽的藥物組合物
IL262058A (en) An oral preparation with unusual extraction capacity
BR112017028140A2 (pt) formulações farmacêuticas
ZA201904241B (en) Novel compound and pharmacologically acceptable salt thereof
ZA202006570B (en) Pharmaceutical formulations
HK1255313A1 (zh) 含有培美曲塞或其藥學上可接受的鹽的穩定藥物組合物
IL290469A (en) Oral pharmaceutical preparation
HK1214600A1 (zh) 種含磷吡啶並 嘧啶- -酮類化合物或其藥學上可接受的鹽、藥物組合物及其應用
HK1245646A1 (zh) 口服給藥用醫藥組合物
KR101790286B9 (ko) -3-디메틸아미노프로폭시]-3'-메톡시비벤질 또는 그의 염을 포함하는 경구용 약학 조성물
PT3632436T (pt) Composição farmacêutica compreendendo sais de lenvatinib
HK1243351A1 (zh) 一種含有吡啶並嘧啶類衍生物或其可藥用鹽的藥物組合物
IL261087B (en) A pharmaceutical composition of cysteamine or a salt thereof with delayed release
ZA202006346B (en) Pharmaceutical preparation
PL3880171T3 (pl) Doustny preparat farmaceutyczny zawierający ibuprofen
RS64906B1 (sr) Farmaceutski preparat
HRP20180819T1 (hr) Farmaceutski pripravak sildenafil-citrata u obliku suspenzije namijenjene oralnoj upotrebi
SG11202101547WA (en) Pharmaceutical composition for oral administration
SG11202010792TA (en) Improved pharmaceutical formulations
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
EP3409662A4 (en) NOVEL CONNECTION AND PHARMACEUTICALLY COMPATIBLE SALT OF WHICH
GB2561723B (en) A composition for oral administration
HK1250633A1 (zh) 口服使用的懸浮液形式的枸櫞酸西地那非的藥物組合物

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant
J202 Request for trial for correction [limitation]
J301 Trial decision

Free format text: TRIAL NUMBER: 2021105000129; TRIAL DECISION FOR CORRECTION REQUESTED 20211110

Effective date: 20220119